Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme?
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 60 (11) , 1099-1104
- https://doi.org/10.1093/jnen/60.11.1099
Abstract
Although there is much written about the molecular definitions of “primary” glioblastomas (GBM), there is little known about the histological features of this predominant subtype. We hypothesized that the “small cell architecture” would represent a histological feature of most primary GBMs. This was tested by comparing the presence of the small cell phenotype with the presence or absence of amplification of the epidermal growth factor receptor (EGFR), a common event in primary GBMs. After a pilot study that found a correlation between this small cell phenotype and EGFR amplification, we selected 9 pure small cell GBMs (SCGBM) and 12 non-SCGBMs to be studied for EGFR amplification by fluorescence in situ hybridization (FISH). In this set of 21 cases, 8 of 9 SCGBMs and 5 of 12 non-SCGBMs were amplified for EGFR. We then correlated the EGFR status of 79 GBMs unselected for their histological features from a set that had been previously characterized in regard to EGFR amplification. Fourteen of 21 (67%) exclusively small cell neoplasms, 8 of 25 (32%) GBMs with both small cell and non-small cell areas, and 3 of 33 (9%) non-small cell GBMs were amplified for EGFR (p = 0.0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of “primary” GBMs.Keywords
This publication has 13 references indexed in Scilit:
- Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction AssayThe American Journal of Pathology, 2001
- Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markersGenes, Chromosomes and Cancer, 2000
- Loss of Heterozygosity on Chromosome 19 in Secondary GlioblastomasJournal of Neuropathology and Experimental Neurology, 2000
- Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed OligoastrocytomasJournal of Clinical Oncology, 2000
- Loss of Heterozygosity on Chromosome 10 Is More Extensive in Primary (De Novo) Than in Secondary GlioblastomasLaboratory Investigation, 2000
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.Journal of Neuropathology and Experimental Neurology, 1998
- Function of aberrant EGFR in malignant gliomas.Brain Tumor Pathology, 1998
- Epidermal growth factor receptor expression in human gliomasCancer Immunology, Immunotherapy, 1991
- Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsiesCancer, 1989